Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
Malignant peripheral nerve sheath tumors (MPNST) are very aggressive malignancies comprising approximately 5-10% of all soft tissue sarcomas. In this study, we focused on pediatric MPNST arising in the first 2 decades of life, as they represent one the most frequent non-rhabdomyosarcomatous soft tis...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b2610436ef346b2aaaba46f9c92e570 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3b2610436ef346b2aaaba46f9c92e570 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3b2610436ef346b2aaaba46f9c92e5702021-11-18T08:44:37ZSurvivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).1932-620310.1371/journal.pone.0080456https://doaj.org/article/3b2610436ef346b2aaaba46f9c92e5702013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24303016/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Malignant peripheral nerve sheath tumors (MPNST) are very aggressive malignancies comprising approximately 5-10% of all soft tissue sarcomas. In this study, we focused on pediatric MPNST arising in the first 2 decades of life, as they represent one the most frequent non-rhabdomyosarcomatous soft tissue sarcomas in children. In MPNST, several genetic alterations affect the chromosomal region 17q encompassing the BIRC5/SURVIVIN gene. As cancer-specific expression of survivin has been found to be an effective marker for cancer detection and outcome prediction, we analyzed survivin expression in 35 tumor samples derived from young patients affected by sporadic and neurofibromatosis type 1-associated MPNST. Survivin mRNA and protein expression were assessed by Real-Time PCR and immunohistochemical staining, respectively, while gene amplification was analyzed by FISH. Data were correlated with the clinicopathological characteristics of patients. Survivin mRNA was overexpressed in pediatric MPNST and associated to a copy number gain of BIRC5; furthermore, increased levels of transcripts correlated with a higher FNCLCC tumor grade (grade 1 and 2 vs. 3, p = 0.0067), and with a lower survival probability (Log-rank test, p = 0.0038). Overall, these data support the concept that survivin can be regarded as a useful prognostic marker for pediatric MPNST and a promising target for therapeutic interventions.Rita AlaggioRiccardo TurriniDaniela BoldrinAnna MerloClaudio GambiniAndrea FerrariPatrizia Dall'ignaCheryl M CoffinAnnalisa MartinesLaura BonaldiGian Luca De SalvoPaola ZanovelloAntonio RosatoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e80456 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rita Alaggio Riccardo Turrini Daniela Boldrin Anna Merlo Claudio Gambini Andrea Ferrari Patrizia Dall'igna Cheryl M Coffin Annalisa Martines Laura Bonaldi Gian Luca De Salvo Paola Zanovello Antonio Rosato Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
description |
Malignant peripheral nerve sheath tumors (MPNST) are very aggressive malignancies comprising approximately 5-10% of all soft tissue sarcomas. In this study, we focused on pediatric MPNST arising in the first 2 decades of life, as they represent one the most frequent non-rhabdomyosarcomatous soft tissue sarcomas in children. In MPNST, several genetic alterations affect the chromosomal region 17q encompassing the BIRC5/SURVIVIN gene. As cancer-specific expression of survivin has been found to be an effective marker for cancer detection and outcome prediction, we analyzed survivin expression in 35 tumor samples derived from young patients affected by sporadic and neurofibromatosis type 1-associated MPNST. Survivin mRNA and protein expression were assessed by Real-Time PCR and immunohistochemical staining, respectively, while gene amplification was analyzed by FISH. Data were correlated with the clinicopathological characteristics of patients. Survivin mRNA was overexpressed in pediatric MPNST and associated to a copy number gain of BIRC5; furthermore, increased levels of transcripts correlated with a higher FNCLCC tumor grade (grade 1 and 2 vs. 3, p = 0.0067), and with a lower survival probability (Log-rank test, p = 0.0038). Overall, these data support the concept that survivin can be regarded as a useful prognostic marker for pediatric MPNST and a promising target for therapeutic interventions. |
format |
article |
author |
Rita Alaggio Riccardo Turrini Daniela Boldrin Anna Merlo Claudio Gambini Andrea Ferrari Patrizia Dall'igna Cheryl M Coffin Annalisa Martines Laura Bonaldi Gian Luca De Salvo Paola Zanovello Antonio Rosato |
author_facet |
Rita Alaggio Riccardo Turrini Daniela Boldrin Anna Merlo Claudio Gambini Andrea Ferrari Patrizia Dall'igna Cheryl M Coffin Annalisa Martines Laura Bonaldi Gian Luca De Salvo Paola Zanovello Antonio Rosato |
author_sort |
Rita Alaggio |
title |
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
title_short |
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
title_full |
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
title_fullStr |
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
title_full_unstemmed |
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). |
title_sort |
survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (mpnst). |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/3b2610436ef346b2aaaba46f9c92e570 |
work_keys_str_mv |
AT ritaalaggio survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT riccardoturrini survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT danielaboldrin survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT annamerlo survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT claudiogambini survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT andreaferrari survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT patriziadalligna survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT cherylmcoffin survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT annalisamartines survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT laurabonaldi survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT gianlucadesalvo survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT paolazanovello survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst AT antoniorosato survivinexpressionandprognosticsignificanceinpediatricmalignantperipheralnervesheathtumorsmpnst |
_version_ |
1718421376496304128 |